Conscience sparks dialogue on open science at the Fonds de solidarité FTQ Life Sciences Symposium
A few weeks ago, Conscience’s Chief Science Officer Aled Edwards and board member Florence Rozen—who also serves as Scientific Director of Investments at the Fonds de solidarité FTQ—participated in a standout panel on open science at the Fonds’ invitation-only Life Sciences Symposium in Montréal. The event marked the Fonds’ 35-year commitment to innovation in Québec’s […]
Announcing a Leadership Transition at Conscience
As we approach the start of a new year, we’re announcing an important transition for Conscience – we are seeking a new CEO and a Director of Program Operations to join our leadership team, and take the organization into the future. Our inaugural CEO, Ryan Merkley, has resigned to pursue a new opportunity, and we […]
AstraZeneca joins CACHE Governing Board
We are pleased to announce that AstraZeneca, a global, science-led biopharmaceutical company has joined the CACHE (Critical Assessment of Computational Hit-finding Experiments) Governing Board for a two-year term, which is a critical element of Conscience’s efforts to set clear industry-leading benchmarks and improve success rates in the current drug discovery system. Bringing a wealth of […]
Will AI Expertise Push Canada Forward As A Biopharma Hub?
In Canada, an impressive roster of machine learning companies and institutions highlights the research being conducted there. However, a paucity of VC funding and few experienced C-suite leaders has stunted the commercialization of great ideas. Read the full article on invivo.citeline.com.
